When should sedation or neuromuscular blockade be used during mechanical ventilation?

Respiratory Care

Volumn 56, Issue 2, 2011, Pages 168-180

  Bennett, Suzanne ^a   Hurford, William E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Agitation; Neuromuscular blockade; Sedation

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CISATRACURIUM; DEXMEDETOMIDINE; GABAPENTIN; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; MORPHINE; NARCOTIC ANALGESIC AGENT; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREGABALIN; PROPOFOL; QUETIAPINE; STEROID; VECURONIUM;

ACUTE KIDNEY TUBULE NECROSIS; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AGITATION; AMNESIA; ANXIETY; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; COMA; CONFUSION; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DEEP SEDATION; DELIRIUM; DRUG DOSE INCREASE; DRUG MEGADOSE; EPIDURAL ANESTHESIA; GASTROINTESTINAL MOTILITY; HALLUCINATION; HEART PRELOAD; HUMAN; HYPEROSMOLARITY; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INTENSIVE CARE; LACTIC ACIDOSIS; LENGTH OF STAY; LOW DRUG DOSE; MORTALITY; NEUROMUSCULAR BLOCKING; NEUROPATHIC PAIN; OXYGEN CONSUMPTION; PAIN; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE ANALGESIA; PROPOFOL INFUSION SYNDROME; RESPIRATION DEPRESSION; RESTLESSNESS; RISK FACTOR; SEDATION; SIDE EFFECT;

ANALGESICS; ANXIETY; CRITICAL CARE; DELIRIUM; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; NEUROMUSCULAR BLOCKING AGENTS; PAIN; RESPIRATION, ARTIFICIAL; VENTILATORS, MECHANICAL;

EID: 79951591745     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01095     Document Type: Article

References (63)

1. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest 1998;114(2):541-548.
2. Arroliga AC, Thompson BT, Ancukiewicz M, Gonzales JP, Guntupalli KK, Park PK, et al. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med 2008;36(4):1083-1088.
3. Fraser GL, Prato BS, Riker RR, Berthiaume D, Wilkins ML. Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU. Pharmacother 2000;20(1):75-82.
4. Woods JC, Mion LC, Conner JT, Viray F, Jahan L, Huber C, et al. Severe agitation among ventilated medical intensive care unit patients: frequency, characteristics and outcomes. Intensive Care Med 2004;30(6):1066-1072.
5. Chanques G, Sebbane M, Barbotte E, Viel E, Eledjam JJ, Jaber S. A prospective study of pain at rest: incidence and characteristics of an unrecognized symptom in surgical and trauma versus medical intensive care unit patients. Anesthesiology 2007;107(5):858-860.
6. Rudin A, Flisberg P, Johansson J, Walther B, Lundberg CJ. Thoracic epidural analgesia or intravenous morphine analgesia after thoracoabdominal esophagectomy: a prospective follow-up of 201 patients. J Cardiothorac Vasc Anesth 2005;19(3):350-357.
7. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30(1):119-141.
8. Pandharipande P, Shintani A, Peterson J, Truman B, Wilkinson GR, Dittus RS, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006;104(1):21-26.
9. Strøm T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomized trial. Lancet 2010;375(9713):475-480.
10. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive acre unit (CAMICU). JAMA 2001;286(21):2703-2710.
11. Pun BT, Ely EW. The importance of diagnosing and managing ICU delirium. Chest 2007;132(2):624-636.
12. Peterson JF, Pun BT, Dittus RS, Thomason JW, Jackson JC, Shintani AK, Ely EW. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 2006;54(3):479-484.
13. Ely EW, Shintani A, Truman B. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004;291(14):1753-1762.
14. Inouye SK, Bogardus ST, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340(9):669-676.
15. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA 1996;275(11):852-857.
16. Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME. A predictive model for delirium in hospitalized elderly medical patients based in admission characteristics. Ann Intern Med 1993;119(6):474-481.
17. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial Lancet 2009;373(9678):1874-1882.
18. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 2001;27(5):859-864.
19. Otter H, Martin J, Basell K, von Heymann C, Hein OV, Bollert P, et al. Validity and reliability of the DDS for severity of delirium in the ICU. Neurocrit Care 2005;2(2):150-158.
20. Inouye Sk, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method: a new method for detection of delirium. Ann Intern Med 1990;113(12):941-948.
21. Kalisvaart KJ, de Jonghe JFM, Bogaards MJ, Vreeswijk R, Egberts TCG, Burger BJ, et al. Haloperidol prophylaxis for elderly hipsurgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005;53(10):1658-1666.
22. Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo- controlled pilot study. Crit Care Med 2010;38(2):419-427.
23. Kahn JM, Andersson L, karir V, Polissar NL, Neff MJ, Rubenfeld GD. Low tidal volume ventilation does not increase sedation use in patients with acute lung injury. Crit Care Med 2005;33(4):766-771.
24. Cheng IW, Eisner MD, Thompson BT, Ware LB, Matthay MA. Acute effects of tidal volume strategy on hemodynamics, fluid balance, and sedation in acute lung injury. Crit Care Med 2005;33(1):63-70.
25. Pohlman MC, McCallister KE, Schweickert WD, Pohlman AS, Nigos CP, Krishnan JA, et al. Excessive tidal volume from breath stacking during lung-protective ventilation for acute lung injury. Crit Care Med 2008;36(11):3019-3023.
26. Sanchez-Izquierdo-Riera JA, Caballero-Cubedo RE, Perez-Vela JL, Ambros-Checa A, Cantalapiedra-Santiago JA, Alted-Lopez E. Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient. Anesth Analg 1998;86(6):1219-1224.
27. Weinbroum AA, Halpern P, Rudick V, Sorkine P, Freedman M, Geller E. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison. Intensive Care Med 1997;23(12):1258-1263.
28. Aitkenhead AR, Willatts SM, Park GR, Collins CH, Ledingham IM, Pepperman ML, et al. Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 1989;2(8665):704-709.
29. Drugs.com editors. FDA approves new indication for Hospira's Precedex (dexmedetomidine HCl) injection. http://www.drugs.com/ newdrugs/fda-approves-new-indication-hospira-s-precedexdexmedetomidine- hcl-1166.html. Accessed December 4, 2010.
30. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298(22):2644-2653.
31. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009;301(5):489-499.
32. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302(17):1872-1879.
33. Gainnier M, Roch A, Forel JM, Thirion X, Arnal JM, Donati S, Papazian L. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004;32(1):113-119.
34. Forel JM, Roch A, Marin V, Michelet P, Demory D, Blache JL, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006;34(11):2749-2757.
35. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363(12):1107-1116.
36. Arroliga A, Frutos-Vivar F, Hall J, Esteban A, Apezteguia C, Soto L, Anzueto A. Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 2005;128(2):496-506.
37. Terao Y, Miura K, Saito M, Sekino M, Fukusaki M, Sumikawa K. Quantitative analysis of the relationship between sedation and resting energy expenditure in postoperative patients. Crit Care Med 2003;31(3): 830-833.
38. Freebairn RC, Derrick J, Gomersall CD, Young RJ, Joynt G. Oxygen delivery, oxygen consumption, and gastric intramucosal pH are not improved by a computer-controlled, closed-loop, vecuronium infusion in severe sepsis and septic shock. Crit Care Med 1997;25(1):72-77.
39. Lagasse RS, Katz RI, Petersen M, Jacobson MJ, Poppers PJ. Prolonged neuromuscular blockade following vecuronium infusion. J Clin Anesth 1990;2(4):269-271.
40. Partridge BL, Abrams JH, Bazemore C, Rubin R. Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 1990;18(10):1177-1179.
41. Margolis BD, Khachikian, Friedman Y, Garrard C. Prolonged reversible quadriparesis in mechanically ventilated patients who received longterm infusions of vecuronium. Chest 1991;100(3):877-878.
42. Op de Coul AA, Lambregts PC, Koeman J, van Puyenbroek MJ, Ter Laak HJ, Gabreëls-Festen AA. Neuromuscular complications in patients given pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985;87(1):17-22.
43. Gooch JL, Suchyta MR, Balbierz JM, Petajan JH, Clemmer TP. Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991;19(9):1125-1131.
44. Meyer KC, Prielipp RC, Grossman JE, Coursin DB. Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994;78(4):772-774.
45. Tabarki B, Coffinieres A, Van den Bergh P, Huault G, Landrieu P, Sebire G. Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects. Arch Dis Child 2002;86(2):103-107.
46. Geller TJ, Kaiboriboon K, Fenton GA, Hayat GR. Vecuroniumassociated axonal motor neuropathy: a variant of critical illness polyneuropathy? Neuromuscul Disord 2001;11(6-7):579-582.
47. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after longterm administration of vecuronium. N Engl J Med 1992;327(8):524-528.
48. Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey Al. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994;17(6):647-654.
49. Hoey LL, Joslin SM, Nahum A, Vance-Bryan K. Prolonged neuromuscular blockade in two critically ill patients treated with atracurium. Pharmacother 1995;15(2):254-259.
50. Vanderheyden BA, Reynolds HN, Gerold KB, Emanuele T. Prolonged paralysis after long-term vecuronium infusion. Crit Care Med 1992;20(2):304-307.
51. Dodson BA, Kelly BJ, Braswell LM, Cohen NH. Changes in acetylcholine receptor number in muscle from critically ill patients receiving muscle relaxants: an investigation of the molecular mechanism of prolonged paralysis. Crit Care Med 1995;23(5):815-821.
52. Rudis M, Sikora CA, Angus E, Peterson E, Popovich J Jr, Hyzy R, Zarowitz BJ. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 1997;25(4):575-583.
53. Road J, Mackie G, Jiang T, Stewart H, Eisen A. Reversible paralysis with status asthmaticus, steriods, and pancuronium: clinical electrophysiological correlates. Muscle Nerve 1997;20(12):1587-1590.
54. David W, Roehr C, Leatherman J. EMG findings in acute myopathy with status asthmaticus, steroids and paralytics: clinical and electrophysiologic correlation. Electromyogr Clin Neurophysiol 1998; (3896):371-376.
55. Zochodne DW, Ramsay DA, Shelley S. Acute necrotizing myopathy of intensive care: electrophysiologic studies. Muscle Nerve 1994; 17(3):285-292.
56. Marik PE. Doxacurium-corticosterid acute myopathy: another piece to the puzzle. Crit Care Med 1996;24(7):1266-1267.
57. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999;27(7):1325-1329.
58. Sessler CN, Gosnell MS, Grap MJ, Brophy GM, ONeal PV, Keane KA, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002;166(100):1338-1344.
59. Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale 9 (RASS). JAMA 2003;289(22):2983-2991.
60. Mascia MF, Koch M, Medicis JJ. Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care. Crit Care Med 2000;28(7):2300-2306.
61. Chanques G, Barbotte JS, Violet S, Sebbane M, Perrigault PF, Mann C, et al. Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med 2006;34(6):1691-1699.
62. Kress JP, Pohlman AS, O'Conner MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000;342(20):1471-1477.
63. Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008;371(9607):126-134.